Interleukin-3 is a predictive marker for severity and outcome during SARS-CoV-2 infections.
Bénard A, Jacobsen A, Brunner M, Krautz C, Klösch B, Swierzy I, Naschberger E, Podolska MJ, Kouhestani D, David P, Birkholz T, Castellanos I, Trufa D, Sirbu H, Vetter M, Kremer AE, Hildner K, Hecker A, Edinger F, Tenbusch M, Mühl-Zürbes P, Steinkasserer A, Richter E, Streeck H, Berger MM, Brenner T, Weigand MA, Swirski FK, Schett G, Grützmann R, Weber GF.
Bénard A, et al. Among authors: david p.
Nat Commun. 2021 Feb 18;12(1):1112. doi: 10.1038/s41467-021-21310-4.
Nat Commun. 2021.
PMID: 33602937
Free PMC article.